PRAME expression was noted in 23 of 53 patients (43.4%), but the non-neoplastic urothelial epithelia around the CIS lesions showed no positive immunoreactivity for PRAME in all cases (p < 0.001). Here, PRAME is linked to in situ carcinoma.